Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange Detected- Page revised to version v3.5.0 with new timestamps (2026-03-12 and 2026-03-16). Previous revision v3.4.3 appears to have been removed.SummaryDifference0.1%

- Check25 days agoChange DetectedWebsite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page shows the addition of Revision: v3.4.2 and the deletion of Revision: v3.4.1 as part of a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page footer, indicating a small page update.SummaryDifference0.0%

- Check67 days agoChange DetectedShow glossary toggle added; 'Last Update Submitted that Met QC Criteria' label updated; 'No FEAR Act Data' note added; and the site revision updated to v3.4.0. These are UI/metadata updates that do not alter the study information.SummaryDifference0.1%

- Check82 days agoChange DetectedMinor update to site revision from v3.3.3 to v3.3.4 with no other observed changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.